MedPath

Investigating the effect of cognitive rehabilitation, Transcranial Alternating Current Stimulation, comibination of and cognitive rehabilitation and Transcranial Alternating Current Stimulation, and the effect of vitamin D on cognitive and executive functions.

Phase 2
Conditions
Mild cognitive impairment.
Other mental disorders due to brain damage and dysfunction and to physical disease
Registration Number
IRCT20230125057214N1
Lead Sponsor
Cognitive Sciences and Technologies Council
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
16
Inclusion Criteria

Over 60 years old
Ability to reading and writing
Having MCI according to MMSE and MOCA
No history of head. injury
Absence of digestive disorders
Not having underlying diseases

Exclusion Criteria

Not wanting to participate in the test and continue the treatment.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The percentage of people whose Montreal Cognitive Assessment scores will improve. Timepoint: Before the start of the test, the second and fourth week and one month after the treatment. Method of measurement: Montreal Cognitive Assessment.;The percentage of people whose Mini-Mental State Examination scores will improve. Timepoint: Before the start of the test, the second and fourth week and one month after the treatment. Method of measurement: Mini-Mental State Examination.
Secondary Outcome Measures
NameTimeMethod
The percentage of people whose Beck Depression Inventory will decrease. Timepoint: Before the start of the test, the second and fourth week and one month after treatment. Method of measurement: Beck's Depression Inventory.
© Copyright 2025. All Rights Reserved by MedPath